Table 2.
Symptoms and diagnoses
| TAIL (n = 1,431) | AH (n = 993) | VH (n = 642) | |
|---|---|---|---|
| Dysfunctional uterine bleeding | 655 (45.7%) | 412 (41.5%) | 349 (54.4%) |
| Postmenopausal bleeding | 109 (7.6%) | 69 (7%) | 31 (4.8%) |
| Cervical intraepithelial neoplasie | 65 (4.5%) | 32 (3.2%) | 64 (10%) |
| Adenomyosis | 221 (15.4%) | 141 (14.2%) | 82 (12.7%) |
| Uterus myomatosus | 758 (52.9%) | 506 (51%) | 240 (37.4%) |
| Benign adnexal tumours | 131 (9.2%) | 107 (10.8%) | 9 (1.4%) |
| Genital prolapse | 156 (10.9%) | 145 (14.6%) | 120 (18.7%) |
| Incontinence | 115 (8%) | 60 (6%) | 52 (8.1%) |
| Endometriosis | 122 (8.5%) | 88 (8.9%) | 10 (1.5%) |
| Dysmenorrhea | 241 (16.8%) | 70 (7%) | 128 (19.9%) |
| Dyspareunia | 62 (4.3%) | 47 (4.7%) | 30 (4.7%) |
| Abdominal pain | 25 (1.7%) | 21 (2.1%) | 11 (1.7%) |
| Miscellaneous | 45 (3.1%) | 29 (2.9%) | 21 (3.3%) |
Patients may have multiple symptoms and/or diagnoses